Published • loading... • Updated
Vlasic Labs CBD Products Qualify for CMS CBD Pilot Program, Marking Historic Step for Cannabinoid Therapies
Summary by Waterloo Cedar Falls Courier
8 Articles
8 Articles
+7 Reposted by 7 other sources
Vlasic Labs CBD Products Qualify for CMS CBD Pilot Program, Marking Historic Step for Cannabinoid Therapies
BLOOMFIELD HILLS, Mich. , March 31, 2026 /PRNewswire/ -- Vlasic Labs today announced that its CBD product line meets the current qualifications outlined in the Centers for Medicare & Medicaid Services (CMS) pilot program, a first-of-its-kind initiative allowing participating healthcare…
·Waterloo, United States
Read Full ArticleCoverage Details
Total News Sources8
Leaning Left0Leaning Right1Center6Last UpdatedBias Distribution86% Center
Bias Distribution
- 86% of the sources are Center
86% Center
C 86%
14%
Factuality
To view factuality data please Upgrade to Premium




